1. Home
  2. SPGI vs MRK Comparison

SPGI vs MRK Comparison

Compare SPGI & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&P Global Inc.

SPGI

S&P Global Inc.

HOLD

Current Price

$422.95

Market Cap

160.5B

Sector

Finance

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$115.63

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPGI
MRK
Founded
1860
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.5B
268.7B
IPO Year
1994
1994

Fundamental Metrics

Financial Performance
Metric
SPGI
MRK
Price
$422.95
$115.63
Analyst Decision
Strong Buy
Buy
Analyst Count
15
14
Target Price
$566.87
$124.29
AVG Volume (30 Days)
2.6M
8.0M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
0.92%
2.93%
EPS Growth
18.70
8.01
EPS
14.66
7.28
Revenue
$6,063,000,000.00
$65,011,000,000.00
Revenue This Year
$9.70
$3.74
Revenue Next Year
$7.36
$5.47
P/E Ratio
$28.65
$15.94
Revenue Growth
7.10
1.31
52 Week Low
$381.61
$75.40
52 Week High
$579.05
$125.14

Technical Indicators

Market Signals
Indicator
SPGI
MRK
Relative Strength Index (RSI) 38.20 45.57
Support Level $400.52 $113.82
Resistance Level $500.93 $125.14
Average True Range (ATR) 10.81 2.78
MACD 1.95 -1.04
Stochastic Oscillator 42.96 18.37

Price Performance

Historical Comparison
SPGI
MRK

About SPGI S&P Global Inc.

S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: